Belluscura PLC (GB:BELL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Belluscura PLC, a UK-based medical device company, has announced the departure of Jonathan Satchell from his position as Non-executive Director effective from 11 July 2024. Satchell, who joined the Board in February 2024 following the acquisition of TMT Acquisition plc, has been praised by Chairman Adam Reynolds for his valuable contributions. Belluscura is known for its focus on developing lightweight and portable oxygen enrichment technology.
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.
